2016
DOI: 10.1021/acs.oprd.6b00268
|View full text |Cite
|
Sign up to set email alerts
|

Development of a Manufacturing Route to Avibactam, a β-Lactamase Inhibitor

Abstract: Process development work to provide an efficient, robust, and cost-effective manufacturing route to avibactam, a β-lactamase inhibitor is presented herewith. Aspects of this optimization work include the counterintuitive introduction of a protecting group to effect a difficult urea formation and the use of controlled feed hydrogenation conditions to facilitate an elegant one pot debenzylation and sulfation reaction. Overall, the commercial process delivers avibactam in much improved yield with significant redu… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
48
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 48 publications
(53 citation statements)
references
References 3 publications
(6 reference statements)
1
48
0
Order By: Relevance
“…Synthesis of avibactam was previously described using chiral piperidine derivatives, l ‐glutamic acid, or l ‐pyroglutamic acid as starting material. Recently, the process has been optimized starting from commercially available Boc‐benzylglutamate . Synthetic efforts devoted to the discovery of new DBOs have also been based on the olefin metathesis reaction or on a lipase catalytic resolution .…”
Section: Figurementioning
confidence: 99%
See 1 more Smart Citation
“…Synthesis of avibactam was previously described using chiral piperidine derivatives, l ‐glutamic acid, or l ‐pyroglutamic acid as starting material. Recently, the process has been optimized starting from commercially available Boc‐benzylglutamate . Synthetic efforts devoted to the discovery of new DBOs have also been based on the olefin metathesis reaction or on a lipase catalytic resolution .…”
Section: Figurementioning
confidence: 99%
“…[13] Synthetic efforts devotedt ot he discoveryo fn ew DBOs have also been based on the olefin metathesis reaction [14] or on al ipase catalytic resolution. [13] Here, we report av ersatile route fort he functionalization of DBOs via the copper(I)-catalyzedH uisgen-Sharpless cycloaddition reaction ( Figure 1c). We show that the resulting triazole-containing DBOs retain the capacity to reach the periplasm of mycobacteria and to inhibit their b-lactamases.…”
mentioning
confidence: 99%
“…20 However, the use of multiple steps and purification sequences is limiting. A process route to Avibactam 21 ( Fig. 1 and Chart 1(v) involved sulfation of the hydroxylamine intermediate using Me 3 NSO 3 , followed by cation exchange with tetrabutylammonium acetate, gave the organosulfate as its tetrabutylammonium salt.…”
mentioning
confidence: 99%
“…This amine exchange has also been observed in the reaction of Et 3 N with PySO 3 . 21 We applied the optimal conditions to the synthesis of a range of sulfate esters (Chart 3). In all examples (Chart 3) we observed a near-quantitative conversion to the corresponding sulfate ester as the tributylammonium salt, independent of both electronic and steric factors.…”
mentioning
confidence: 99%
“…This allowed to isolate the (S/R) isomer of piperidine 22 with a 56% overall yield on a 300 kg scale. 32 Since only the trans isomer of 22 was isolated, the tedious selective saponification step could be avoided and amide 24 was directly obtained in 92% yield by treatment with a methanolic solution of ammonia (Scheme 5). A selective Fmocprotection of the amine was necessary before activating the hydroxylamine with carbonyldiimidazole to give intermediate 25.…”
Section: Subsequent Improvements (Astrazeneca/forest)mentioning
confidence: 99%